Molecular analysis of the CYP21 gene and prenatal diagnosis in families with 21-hydroxylase deficiency in Northeastern Iran

Hormone Research

Volumn 63, Issue 3, 2005, Pages 119-124

  Vakili, Rahim ^a   Baradaran Heravi, Alireza ^a,b   Barid Fatehi, Babak ^a,b   Gholamin, Mehran ^b   Ghaemi, Nosrat ^a   Abbaszadegan, Mohammad Reza ^a,b  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

21 Hydroxylase deficiency; Congenital adrenal hyperplasia; Polymerase chain reaction; Prenatal diagnosis

Indexed keywords

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; CONGENITAL ADRENAL HYPERPLASIA; CONTROLLED STUDY; CORRELATION ANALYSIS; CYP21 GENE; FEMALE; GENE; GENE DELETION; GENE MUTATION; GENETIC ANALYSIS; GENOTYPE; HUMAN; INFANT; MALE; MOLECULAR DYNAMICS; NEWBORN; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS;

ADOLESCENT; ADRENAL HYPERPLASIA, CONGENITAL; ADULT; CHILD; CHILD, PRESCHOOL; FEMALE; GENETIC SCREENING; GENOTYPE; HUMANS; INFANT; INFANT, NEWBORN; IRAN; MALE; PHENOTYPE; POINT MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PREGNANCY; PRENATAL DIAGNOSIS; STEROID 21-HYDROXYLASE;

EID: 18744364711     PISSN: 03010163     EISSN: None     Source Type: Journal    
DOI: 10.1159/000084570     Document Type: Article

References (34)

1. Asanuma A, Ohura T, Ogawa E, Sato S, Igarashi Y, Matsubara Y, Iinuma K: Molecular analysis of Japanese patients with steroid 21-hydroxylase deficiency. J Hum Genet 1999;44: 312-317.
2. White PC, Speiser PW: Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocr Res 2000;21:245-291.
3. Nordenstrom A, Thilen A, Hagenfeldt, Larsson A, Wedell A: Genotyping is a valuable diagnostic complement to neonatal screening for congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency. J Clin Endocrinol Metab 1999;84:1505-1509.
4. Koppens PF, Hoogenboezem T, Degenhart HJ: Carriership of a defective tenascin-X gene in steroid 21-hydroxylase deficiency patients: TNXB-TNXA hybrids in apparent large-scale gene conversions. Hum Mol Genet 2002;11: 2581-2590.
5. Therrell BL: Newborn screening for congenital adrenal hyperplasia. Endocrinol Metab Clin North Am 2001;30:15-30.
6. Speiser PW, White PC : Congenital adrenal hyperplasia. N Engl J Med 2003;349:776-788.
7. Lajic' S, Clauin S, Robins T, Vexiau P, Blanche H, Bellanne-Chantelot C, Wedell A: Novel mutations in CYP21 detected in individuals with hyperandrogenism. J Clin Endocrinol Metab 2002;87:2824-2829.
8. Krone N, Braun A, Weinert S, Peter M, Roscher AA, Partsch C, Sippell WG: Multiplex minisequencing of the 21-hydroxylase gene as a rapid strategy to confirm congenital adrenal hyperplasia. Clin Chem 2002;48:818-825.
9. Higashi Y, Tanae A, Inoue H, Fujii-Kuriyama Y: Evidence for frequent gene conversion in the steroid 21-hydroxylase P-450(C21) gene: Implications for steroid 21-hydroxylase deficiency. Am J Hum Genet 1988;42:17-25.
10. Tajima T, Fujieda K, Nakayama K, Fujii-Kuriyama Y: Molecular analysis of patient and carrier genes with congenital steroids 21-hydroxylase deficiency by using polymerase chain reaction and single strand conformation polymorphism. J Clin Invest 1993;92:2182-2190.
11. Siegel SF, Hoffman EP, Trucco M: Molecular diagnosis of 21-hydroxylase deficiency: Detection of four mutations on a single gel. Biochem Med Metab Biol 1994;51:66-73.
12. Ogawa E, Ohura T, Igarashi Y, Narisawa K, Tada K: Genetic analysis of classical 21-hydroxylase deficiency using polymerase chain reaction and allele-specific oligonucleotide hybridization. Clin Pediatr Endocrinol 1993;2: 125-132.
13. Wilson RC, Mercado AB, Cheng KC, New MI: Steroid 21-hydroxylase deficiency: Genotype may not predict phenotype. J Clin Endocrinol Metab 1995;80:2322-2329.
14. Speiser PW, Dupont J, Zhu D, Serrat J, Buegeleisen M, Tusie-Luna MT, Lesser M, New MI, White PC: Disease expression and molecular genotype in congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Invest 1992;90:584-595.
15. Wedell A, Thilen A, Ritzen EM, Stengler B, Luthman H: Mutational spectrum of the steroid 21-hydroxylase gene in Sweden: Implications for genetic diagnosis and association with disease manifestations. J Clin Endocrinol Metab 1994;78:1145-1152.
16. Ezquieta B, Oliver A, Gracia R, Gancedo PG: Analysis of steroid 21-hydroxylase gene mutations in the Spanish population. Hum Genet 1995;96:198-204.
17. Paulino LC, Araujo M, Guerra GJ, Marini SH, De Mello MP: Mutation distribution and CYP21/C4 locus variability in Brazilian families with the classical form of the 21-hydroxylase deficiency. Acta Paediatr 1999;88:275-283.
18. Dardis A, Bergada I, Bergada C, Rivarola M, Belgorosky A: Mutations of the steroid 21-hydroxylase gene in an Argentinian population of 36 patients with classical congenital adrenal hyperplasia. J Pediatr Endocrinol Metab 1997; 10:55-61.
19. Lako M, Ramsden S, Campbell RD, Strachan T: Mutation screening in British 21-hydroxylase deficiency families and development of novel microsatellite based approaches to prenatal diagnosis. J Med Genet 1999;36:119-124.
20. Higashi Y, Hiromasa T, Tanae A, Miki T, Nakura J, Kondo T, Ohura T, Ogawa E, Nakayama K, Fujii-Kuriyama Y: Effects of individual mutations in the P-450(C21) pseudogene on the P-450(C21) activity and their distribution in the patient genomes of congenital steroid 21-hydroxylase deficiency. J Biochem (Tokyo) 1991;109:638-644.
21. Ko TM, Kao CH, Ho HN, Tseng LH, Hwa HL, Hsu PM, Chuang SM, Lee TY: Congenital adrenal hyperplasia. Molecular characterization. J Reprod Med 1998;43:379-386.
22. Witchel SF, Smith R, Crivellaro CE, Della Manna T, Dichtchekenian V, Setian N, Damiani D: CYP21 mutations in Brazilian patients with 21-hydroxylase deficiency. Hum Genet 2000;106:414-419.
23. Vakili R: Congenital adrenal hyperplasia in north-east of Iran: A review of 47 patients and the role of parental consanguinity in the occurrence of disease. Med J IRI 2002;16:75-78.
24. Levine LS, Digeoge AM: Congenital adrenal hyperplasia; in Behrman RE, Kliegman RM, Jenson HB (eds): Nelson Textbook of Pediatrics, ed 16. Philadelphia, Saunders, 2000, pp 1730-1736.
25. Pang S, Wallace MA, Hofman L, Thuline HC, Dorche C, Lyon ICT, Dobbins RH, Kling S, Fujieda K, Suwa S: Worldwide experience in newborn screening for classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Pediatrics 1988;81:866-874.
26. Lebovitz RM, Pauli RM, Laxova R: Delayed diagnosis in congenital adrenal hyperplasia. Need for newborn screening. Am J Dis Child 1984;138:571-573.
27. Thompson R, Seargeant L, Winter JS: Screening for congenital adrenal hyperplasia: Distribution of 17α-hydroxyprogesterone concentrations in neonatal blood spot specimens. J Pediatr 1989;114:400-404.
28. Thilen A, Larsson A: Congenital adrenal hyperplasia in Sweden 1969-1986. Prevalence, symptoms and age at diagnosis. Acta Paediatr Scand 1990;79:168-175.
29. Therrell BLJ, Berenbaum SA, Manter-Kapanke V, Simmank J, Korman K, Prentice L, Gonzalez J, Gunn S: Results of screening 1.9 million Texas newborns for 21-hydroxylase-deficient congenital adrenal hyperplasia. Pediatrics 1998;101:583-590.
30. Balsamo A, Cacciari E, Piazzi S, Cassio A, Bozza A, Pirazzoli P, Zappulla F: Congenital adrenal hyperplasia: Neonatal mass screening compared with clinical diagnosis only in the Emilia-Romagna region of Italy, 1980-1995. Pediatrics 1996;98:362-367.
31. Thil'en A, Nordenstrom A, Hagenfeldt L, von Dobeln U, Guthenberg C, Larsson A: Benefits of neonatal screening for congenital adrenal hyperplasia (21-hydroxylase deficiency) in Sweden. Pediatrics 1998;101:E11.
32. Brosnan PG, Brosnan CA, Kemp SF, Domek DB, Jelley DH, Blackett PR, Riley WJ: Effect of newborn screening for congenital adrenal hyperplasia. Arch Pediatr Adolesc Med 1999; 153:1272-1278.
33. Family Planning Unit: Khorasan Province Health Center, Iran, unpublished data, 2002.
34. Speiser PW, White PC, Dupont J, Zhu D, Mercado AB, New MI: Prenatal diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency by allele-specific hybridization and Southern blot. Hum Genet 1994;93:424-428.